Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32780
Title: Disability accrual in primary and secondary progressive multiple sclerosis.
Austin Authors: Harding-Forrester, Sam;Roos, Izanne;Nguyen, Ai-Lan;Malpas, Charles B;Diouf, Ibrahima;Moradi, Nahid;Sharmin, Sifat;Izquierdo, Guillermo;Eichau, Sara;Patti, Francesco;Horakova, Dana;Kubala Havrdova, Eva;Prat, Alexandre;Girard, Marc;Duquette, Pierre;Grand'Maison, Francois;Onofrj, Marco;Lugaresi, Alessandra;Grammond, Pierre;Ozakbas, Serkan;Amato, Maria Pia;Gerlach, Oliver;Sola, Patrizia;Ferraro, Diana;Buzzard, Katherine;Skibina, Olga;Lechner-Scott, Jeannette;Alroughani, Raed;Boz, Cavit;Van Pesch, Vincent;Cartechini, Elisabetta;Terzi, Murat;Maimone, Davide;Ramo-Tello, Cristina;Yamout, Bassem;Khoury, Samia Joseph;La Spitaleri, Daniele;Sa, Maria Jose;Blanco, Yolanda;Granella, Franco;Slee, Mark;Butler, Ernest;Sidhom, Youssef;Gouider, Riadh;Bergamaschi, Roberto;Karabudak, Rana;Ampapa, Radek;Sánchez-Menoyo, José Luis;Prevost, Julie;Castillo-Trivino, Tamara;McCombe, Pamela A;Macdonell, Richard A L ;Laureys, Guy;Van Hijfte, Liesbeth;Oh, Jiwon;Altintas, Ayse;de Gans, Koen;Turkoglu, Recai;van der Walt, Anneke;Butzkueven, Helmut;Vucic, Steve;Barnett, Michael;Cristiano, Edgardo;Hodgkinson, Suzanne;Iuliano, Gerardo;Kappos, Ludwig;Kuhle, Jens;Shaygannejad, Vahid;Soysal, Aysun;Weinstock-Guttman, Bianca;Van Wijmeersch, Bart;Kalincik, Tomas
Affiliation: CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Multiple Sclerosis Unit, Hospital Universitario Virgen Macarena, Sevilla, Andalucía, Spain.
Neuroscience, Department of Surgical and Medical Sciences and Advanced Technologies 'G.F. Ingrassia', University of Catania, Catania, Italy.
Department of Neurology and Centre of Clinical Neuroscience, Charles University First Faculty of Medicine, Praha, Czech Republic.
Centre Hospitalier, Université de Montréal, Montreal, Québec, Canada.;Faculté de Médecine, Université de Montréal, Montreal, Québec, Canada.
Neuro Rive-Sud, Longueuil, Quebec, Canada.
Department of Neurosciences, Imaging and Clinical Sciences, Gabriele d'Annunzio University of Chieti-Pescara, Chieti, Italy.
UOSI Riabilitazione Sclerosi Multipla, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.;Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
Centre intégré de santé et de services sociaux de Chaudière-Appalaches du Québec Centre de Recherche, Levis, Québec, Canada.
Department of Neurology, Dokuz Eylul University, İzmir, Turkey.
Department of Neurological Siences, University of Florence, Florence, Italy.;IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Department of Neurology, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands.
Neurology Unit, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy.
Department of Neuroscience, Azienda Ospedaliero-Universitaria di Modena, Modena, Emilia-Romagna, Italy.;Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Department of Neurology, Box Hill Hospital, Box Hill, Victoria, Australia.
School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.;Department of Neurology, John Hunter Hospital, Newcastle, New South Wales, Australia.
Department of Medicine, Al-Amiri Hospital, Kuwait City, Kuwait.
Department of Neurology, Karadeniz Technical University, Trabzon, Turkey.
Department of Neurology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
UOC Neurologia, Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy.
Ondokuz Mayis Üniversitesi, Samsun, Turkey.
UO Neurologia, Ospedale Garibaldi, Catania, Italy.
Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.;Department of Neurology, American University of Beirut, Beirut, Lebanon.
Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.;American University of Beirut, Beirut, Lebanon.
UOC Neurologia e Stroke, AORN San Giuseppe Moscati, Avellino, Italy.
Department of Neurology, Centro Hospitalar de São João, Porto, Portugal.;Health Sciences Faculty, Fernando Pessoa University, Porto, Portugal.
Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
Multiple Sclerosis Centre, Neurosciences, University of Parma, Parma, Italy.
Department of Neurology, Flinders Medical Centre, Adelaide, South Australia, Australia.
Department of Neurology, Monash Medical Centre Clayton, Clayton, Victoria, Australia.
Department of Neurology, Hopital Razi, La Manouba, Tunisia.
Department of Neurology, Razi Hospital, Rasht, Gilan, Iran.
Multiple Sclerosis Centre, Neurological Institute C.Mondino, Pavia, Italy.
Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Department of Neurology, Nemocnice Jihlava, Jihlava, Czech Republic.
Department of Neurology, Hospital Galdakao-Usansolo, Galdacano, País Vasco, Spain.
Centre integre de sante et de services sociaux des Laurentides point de service de Saint-Jerome, Saint-Jerome, Quebec, Canada.
Department of Neurology, Donostia University Hospital, San Sebastian, Spain.
UQCCR, The University of Queensland, Saint Lucia, Queensland, Australia.
Neurology
Department of Neurology, University Hospital Ghent, Gent, Oost-Vlaanderen, Belgium.
Division of Neurology, Department of Medicine, St Michael's Hospital, Toronto, Ontario, Canada.
Department of Neurology, Koc Universitesi, Istanbul, Turkey.;Koç University Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.
Department of Neurology, Groene Hart Ziekenhuis, Gouda, Zuid-Holland, The Netherlands.
Department of Neurology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
Multiple Sclerosis and Neuroimmunology Unit, Monash University Central Clinical School, Melbourne, Victoria, Australia.
Department of Neuroscience, Monash University Central Clinical School, Melbourne, Victoria, Australia.;Department of Neurology, The Alfred, Melbourne, Victoria, Australia.
Department of Neurology, Westmead Hospital, Westmead, New South Wales, Australia.
Brain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
Centro de Esclerosis Múltiple de Buenos Aires, Hospital Italiano de Buenos Aires, Buenos Aires, Federal District, Argentina.
Department of Neurology, Liverpool Hospital, Liverpool, New South Wales, Australia.
Ospedali Riuniti di Salerno, Salerno, Italy.
Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine, and Clinical Research, University Hospital Basel, Basel, Switzerland.;Research Centre for Clinical Neuroimmunology and Neuroscience, University Hospital Basel, Basel, Switzerland.
Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Neurology, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Istanbul, Turkey.
Department of Neurology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
Universitair MS Centrum, Hasselt University, Hasselt-Pelt, Belgium.;Rehabilitation & MS Centre, Pelt, Belgium.
Issue Date: 17-Apr-2023
Date: 2023
Publication information: Journal of Neurology, Neurosurgery, and Psychiatry 2023-09; 94(9)
Abstract: Some studies comparing primary and secondary progressive multiple sclerosis (PPMS, SPMS) report similar ages at onset of the progressive phase and similar rates of subsequent disability accrual. Others report later onset and/or faster accrual in SPMS. Comparisons have been complicated by regional cohort effects, phenotypic differences in sex ratio and management and variable diagnostic criteria for SPMS. We compared disability accrual in PPMS and operationally diagnosed SPMS in the international, clinic-based MSBase cohort. Inclusion required PPMS or SPMS with onset at age ≥18 years since 1995. We estimated Andersen-Gill hazard ratios for disability accrual on the Expanded Disability Status Scale (EDSS), adjusted for sex, age, baseline disability, EDSS score frequency and drug therapies, with centre and patient as random effects. We also estimated ages at onset of the progressive phase (Kaplan-Meier) and at EDSS milestones (Turnbull). Analyses were replicated with physician-diagnosed SPMS. Included patients comprised 1872 with PPMS (47% men; 50% with activity) and 2575 with SPMS (32% men; 40% with activity). Relative to PPMS, SPMS had older age at onset of the progressive phase (median 46.7 years (95% CI 46.2-47.3) vs 43.9 (43.3-44.4); p<0.001), greater baseline disability, slower disability accrual (HR 0.86 (0.78-0.94); p<0.001) and similar age at wheelchair dependence. We demonstrate later onset of the progressive phase and slower disability accrual in SPMS versus PPMS. This may balance greater baseline disability in SPMS, yielding convergent disability trajectories across phenotypes. The different rates of disability accrual should be considered before amalgamating PPMS and SPMS in clinical trials.
URI: https://ahro.austin.org.au/austinjspui/handle/1/32780
DOI: 10.1136/jnnp-2022-330726
ORCID: 0000-0002-5019-9199
0000-0003-0371-3666
0000-0003-0534-3718
0000-0001-7294-9723
0000-0001-9159-3128
0000-0002-0480-2495
0000-0003-4818-3806
0000-0003-3198-6063
0000-0001-9615-3797
0000-0002-9249-3185
0000-0003-2704-8517
0000-0002-4278-7003
0000-0002-8323-873X
0000-0003-4175-5509
0000-0003-3778-1376
Journal: Journal of Neurology, Neurosurgery, and Psychiatry
PubMed URL: 37068931
ISSN: 1468-330X
Type: Journal Article
Subjects: multiple sclerosis
Appears in Collections:Journal articles

Show full item record

Page view(s)

66
checked on Nov 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.